Clinical trial
Prospective Randomized Study on the Efficacy of Endoscopic Injection Therapy With Fibrin Sealant Versus Endoscopic Ligature for Acute Hemostasis and the Prophylaxis of Recurrent Bleeding From Esophageal Varices
NCT00161915 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Study on the Efficacy of Endoscopic Injection Therapy With Fibrin Sealant Versus Endoscopic Ligature for Acute Hemostasis and the Prophylaxis of Recurrent Bleeding From Esophageal Varices
- Lead sponsor
- Baxter Healthcare Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2000
- Completion date
- January 31, 2004
- Enrollment
- Not reported
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal and/or gastric varices